Northwestern Univ meical School/Robert H. Lurie Comprehensive Cancer Center

Chicago, Illinois 60611

0 studies enrolling now · 1 studies all time

What they study most

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Studies at this site

• An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha — Completed